Answers are grounded in this paper and cite their sources.
Intracerebral hemorrhage (ICH) is a devastating subtype of stroke associated with high rates of mortality, long-term disability, and recurrence. Growing evidence indicates that hemorrhage location is closely associated with differences in underlying vascular pathology, disease progression, clinical outcomes, and treatment response. This narrative review critically synthesizes current evidence on location-specific heterogeneity in spontaneous ICH, encompassing etiology, hematoma expansion, intraventricular extension, hydrocephalus, functional outcomes, recurrence, and therapeutic management. Deep ICH is predominantly associated with hypertensive small vessel disease, whereas lobar and superficial cerebellar hemorrhages are more frequently linked to cerebral amyloid angiopathy. Although location-related differences in hematoma expansion have been reported, findings remain inconsistent owing to variations in outcome definitions, imaging timing, patient characteristics, and study methodology. Hemorrhage location is also associated with differences in the prognostic significance of hematoma volume, susceptibility to ventricular extension and hydrocephalus, and patterns of neurological and cognitive recovery. Lobar ICH generally carries a higher risk of recurrence, particularly in the presence of cerebral amyloid angiopathy-related imaging markers. Emerging evidence further suggests that hemorrhage location may influence responses to acute blood pressure management and the risk–benefit balance of antithrombotic therapy. However, much of the available evidence derives from observational studies and secondary analyses, and robust evidence supporting location-specific therapeutic strategies remains limited. Collectively, these findings highlight hemorrhage location as an important dimension of ICH heterogeneity that may complement established clinical and imaging parameters in prognostic assessment and individualized management. Future prospective investigations and adequately powered, location-stratified randomized controlled trials are warranted to establish whether integrating anatomical location into clinical decision-making improves patient outcomes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: